Agilent Technologies (A) Projected to Post Earnings on Wednesday

Agilent Technologies (NYSE:A) is anticipated to announce its Q3 2026 results after the market closes on Wednesday, August 26th. Analysts expect Agilent Technologies to announce earnings of $1.49 per share and revenue of $1.8415 billion for the quarter. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Interested persons can find conference call details on the company’s upcoming Q3 2026 earning overview page for the latest details on the call scheduled for Wednesday, August 26, 2026 at 4:30 PM ET.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. The business had revenue of $1.83 billion during the quarter, compared to analysts’ expectations of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company’s quarterly revenue was up 10.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.31 earnings per share. On average, analysts expect Agilent Technologies to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Agilent Technologies Stock Performance

NYSE A opened at $153.37 on Tuesday. The stock’s 50 day simple moving average is $138.03 and its 200-day simple moving average is $126.32. Agilent Technologies has a 1-year low of $108.35 and a 1-year high of $160.51. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. The company has a market cap of $43.32 billion, a PE ratio of 30.80, a price-to-earnings-growth ratio of 2.80 and a beta of 1.25.

Analyst Ratings Changes

A has been the subject of a number of recent research reports. Jefferies Financial Group initiated coverage on shares of Agilent Technologies in a research report on Thursday, July 9th. They issued a “hold” rating and a $135.00 target price for the company. Weiss Ratings raised Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. Morgan Stanley increased their price objective on shares of Agilent Technologies from $160.00 to $175.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 12th. Bank of America raised Agilent Technologies from a “neutral” rating to a “buy” rating and dropped their target price for the company from $150.00 to $145.00 in a research report on Thursday, May 28th. Finally, Piper Sandler began coverage on shares of Agilent Technologies in a research note on Thursday, June 11th. They issued a “neutral” rating and a $150.00 price target for the company. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $160.24.

Institutional Investors Weigh In On Agilent Technologies

Large investors have recently modified their holdings of the stock. State of Wyoming acquired a new stake in Agilent Technologies in the second quarter valued at about $35,000. Transamerica Financial Advisors LLC lifted its holdings in shares of Agilent Technologies by 180.8% in the fourth quarter. Transamerica Financial Advisors LLC now owns 337 shares of the medical research company’s stock valued at $46,000 after purchasing an additional 217 shares in the last quarter. Johnson Financial Group Inc. acquired a new stake in Agilent Technologies during the 3rd quarter valued at $49,000. DV Equities LLC acquired a new stake in shares of Agilent Technologies during the fourth quarter valued at $54,000. Finally, Itau Unibanco Holding S.A. acquired a new stake in shares of Agilent Technologies during the 4th quarter worth about $58,000.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.